BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21461585)

  • 1. MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition.
    Park WH
    Mol Med Rep; 2011; 4(1):193-04. PubMed ID: 21461585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    You BR; Park WH
    J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
    Park WH
    Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
    Park WH; Kim SH
    Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of gallic acid-induced human pulmonary fibroblast cell death by N-acetyl cysteine and L-buthionine sulfoximine.
    You BR; Park WH
    Hum Exp Toxicol; 2011 Aug; 30(8):992-9. PubMed ID: 20921063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
    Park WH
    Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of reactive oxygen species and glutathione in gallic acid-induced human umbilical vein endothelial cell death.
    Park WH; Kim SH
    Oncol Rep; 2012 Aug; 28(2):695-700. PubMed ID: 22665164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase.
    You BR; Park WH
    Toxicol In Vitro; 2010 Aug; 24(5):1356-62. PubMed ID: 20417267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Park WH
    Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MEK inhibitor PD98059 attenuates growth inhibition and death in gallic acid-treated Calu-6 lung cancer cells by preventing glutathione depletion.
    Han YH; Moon HJ; You BR; Yang YM; Kim SZ; Kim SH; Park WH
    Mol Med Rep; 2010; 3(3):519-25. PubMed ID: 21472273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
    Park WH
    Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallic acid-induced human pulmonary fibroblast cell death is accompanied by increases in ROS level and GSH depletion.
    You BR; Park WH
    Drug Chem Toxicol; 2011 Jan; 34(1):38-44. PubMed ID: 20954801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimycin A induces death of the human pulmonary fibroblast cells via ROS increase and GSH depletion.
    Park WH; You BR
    Int J Oncol; 2016 Feb; 48(2):813-20. PubMed ID: 26647857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of MAPK inhibitors on antimycin A-treated calf pulmonary arterial endothelial cells in relation to cell death, reactive oxygen species and glutathione.
    Han YH; You BR; Moon HJ; Kim SZ; Kim SH; Park WH
    Mol Med Rep; 2010; 3(1):161-6. PubMed ID: 21472216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion.
    Han YH; Park WH
    Arch Toxicol; 2010 Aug; 84(8):631-40. PubMed ID: 20191265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 inhibitor enhances growth inhibition and death in gallic acid-treated endothelial cells.
    Yang YM; Park WH
    Int J Mol Med; 2010 Aug; 26(2):295-300. PubMed ID: 20596611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    Park WH; Kim SH
    Oncol Rep; 2012 Apr; 27(4):1284-91. PubMed ID: 22266922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibition by MG132 induces growth inhibition and death of human pulmonary fibroblast cells in a caspase-independent manner.
    You BR; Park WH
    Oncol Rep; 2011 Jun; 25(6):1705-12. PubMed ID: 21399877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.